The Third Annual Health 2.0 Europe Conference in Berlin

6 – 7 November 2012, Berlin, Germany.
Healthcare is changing profoundly due to new web and mobile applications. The conference Health 2.0 Europe addresses recent developments in this emerging field. The 2012 edition features exciting live technology demos and panels dedicated to answering the most urgent questions in health care.

The Health 2.0 Europe conference promotes a new ecosystem for health innovation, and gathers together over 300 health entrepreneurs, IT solution providers, health professionals, patient organizations, health authorities, insurers, pharmaceutical companies, telecom groups, VCs and financiers, policy makers, and many more.

A few examples from the 50+ LIVE technology demos presented at the conference

  • iDoc24 cell phone-based dermatology consultation service
  • Isabel symptom checker empowering patients to search the right information and ask the right questions
  • Drugee platform collecting adverse drug reactions from patients and health professionals
  • Thryve mobile food coach, which listens to your body and helps you figure out what you should eat more of, and what you should avoid
  • Medting web-based platform for clinical case collaboration allowing doctors to request second opinions from other doctors around the world

The Health 2.0 Europe 2012 Agenda topics include

  • Patient communities and physician networks
  • Health 2.0: transforming hospitals and physicians’ practices
  • Financing Health 2.0
  • Compliance, Chronic Care and Population Health Management
  • Health promotion and Wellness 2.0
  • Sexual health, mental health, addictions, and other “unmentionables”

Inspirational speakers Tim KELSEY, the Executive Director of Transparency and Open Data for the UK Government, and Peter LEVIN, the Senior Advisor to the Secretary and CTO at the US Department of Veterans Affairs, will be among the 75 speakers carefully selected from over 25 different countries.

A special session on Health 2.0 for Pharma, moderated by Alexander SCHACHINGER of Healthcare 42 in Germany, will discuss how to best collaborate with doctors and about engaging patients. The session will also address questions on how to make the most of data, how to unleash clinical development, and how to avoid the numerous potential pitfalls.

To encourage their participation, Health 2.0 Europe is extending free registration for patient organization representatives.

Promoting ideation and innovation from all angles, Health 2.0 Europe 2012 also features a two-day “Code-A-Thon” on November 3 – 4 that brings together developers, designers, healthcare professionals and patients to create new and exciting applications for improved health and wellness. Registration to this event is free and 9,000 € in cash prizes will be distributed to the winners.

Register today for best way to get up to speed with the latest developments in Health 2.0.

For further information, please visit:
http://www.health2con.com/events/conferences/europe-fall-2012/

About Health 2.0 Europe
Health 2.0 Europe is the premier conference exploring how web, mobile and social technologies are transforming health care systems in Europe. As an organization, Health 2.0 has introduced over 500 technology companies to the world stage, hosted more than 9,000 attendees at conferences and code-a-thons, awarded over $1,400,000 in prizes through developer challenge programs and inspired the formation of 46 new city chapters around the globe. Health 2.0 isn’t a company, it’s a movement.

New pharmacovigilance legislation comes into operation

Better protection of public health through strengthened EU system for medicines safety

02/07/2012 - The European Medicines Agency (EMA) welcomes the start of new European Union (EU) legislation on pharmacovigilance. This new piece of legislation aims to promote and protect public health by strengthening the existing Europe-wide system for monitoring the safety and benefit-risk balance of medicines.

“The progress made in healthcare would not have been possible without medicines and the research and development community behind them. But we need smart regulation for the system to be able to continue to deliver safe and effective medicines,” said the Agency’s Executive Director, Guido Rasi.

“The new pharmacovigilance legislation will help us to make the system more robust for public health and more transparent. It gives regulators a range of new or improved tools to ensure that patients are not exposed to unnecessary risks when taking medicines. It also increases the efficiency of medicines regulation for the benefit of all stakeholders.”

The new legislation was proposed by the European Commission in 2008 and adopted by the European Parliament and the Member States in December 2010. Highlights of the new legislation include:

  • establishment of a new scientific committee, the Pharmacovigilance Risk Assessment Committee (PRAC);
  • clarification of the roles and responsibilities of all actors involved in the monitoring of the safety and efficacy of medicines in Europe and strengthened coordination, leading to more robust and rapid EU decision-making;
  • engagement of patients and healthcare professionals in the regulatory process, including direct consumer reporting of suspected adverse drug events;
  • improved collection of key information on medicines, e.g. through risk-proportionate, mandatory post-authorisation safety and efficacy studies;
  • more transparency and better communication, including publication of agendas and minutes of the PRAC and the possibility to hold public hearings.

The Agency is ready for the first meeting of the PRAC on 19 and 20 July 2012. All Member States have nominated their members. The European Commission has appointed six independent scientific experts who will also serve as members. The nomination of PRAC members representing patients and healthcare professionals will follow a new public call for expressions of interest.

Information about the roles and the functioning of the PRAC has been published today and can be found on the Agency’s website, together with more information about the new pharmacovigilance legislation.

Notes
1. This press release, together with all related documents, is available on the Agency’s website.
2. More information on the new pharmacovigilance legislation is available here.
3. The status report ‘Countdown to July 2012: the Establishment and Functioning of the PRAC’ is available on the Agency’s website.
4. The new pharmacovigilance legislation is comprised of Directive 2010/84/EU and Regulation (EU) No 1235/2010.
5. More information on the work of the European Medicines Agency can be found on its website

Language Barriers to Health Care in the United States

This perspective article was written and published back in 2006 by Glenn Flores, M.D. in the New England Journal of Medicine (N Engl J Med 2006; 355:229-231 - July 20, 2006) yet it remains dramatically and sadly true today, 6 years later.

A 12-year-old Latino boy arrived at a Boston emergency department with dizziness and a headache. The patient, whom I’ll call Raul, had limited proficiency in English; his mother spoke no English, and the attending physician spoke little Spanish. No medical interpreter was available, so Raul acted as his own interpreter. His mother described his symptoms:

La semana pasada a el le dio mucho mareo y no tenía fiebre ni nada, y la familia por parte de papá todos padecen de diabetes.”(Last week, he had a lot of dizziness, and he didn’t have fever or anything, and his dad’s family all suffer from diabetes.)

“Uh hum,” replied the physician.

The mother went on. “A mí me da miedo porque el lo que estaba mareado, mareado, mareado y no tenía fiebre ni nada.” (I’m scared because he’s dizzy, dizzy, dizzy, and he didn’t have fever or anything.)

Turning to Raul, the physician asked, “OK, so she’s saying you look kind of yellow, is that what she’s saying?”

Raul interpreted for his mother: “Es que si me vi amarillo?” (Is it that I looked yellow?)

“Estaba como mareado, como pálido” (You were like dizzy, like pale), his mother replied.

Raul turned back to the doctor. “Like I was like paralyzed, something like that,” he said.

If Raul received inappropriate care owing to his misinterpretation, he would not be alone. One interpreter, mistranslating for a nurse practitioner, told the mother of a seven-year-old girl with otitis media to put (oral) amoxicillin “in the ears.” In another case, a Spanish-speaking woman told a resident that her two-year-old had “hit herself” when she fell off her tricycle; the resident misinterpreted two words, understood the fracture to have resulted from abuse, and contacted the Department of Social Services (DSS). DSS sent a worker who, without an interpreter present, had the mother sign over custody of her two children. Clearly, catastrophes can and do result from such miscommunication.

Some 49.6 million Americans (18.7 percent of U.S. residents) speak a language other than English at home; 22.3 million (8.4 percent) have limited English proficiency, speaking English less than “very well,” according to self-ratings. Between 1990 and 2000, the number of Americans who spoke a language other than English at home grew by 15.1 million (a 47 percent increase), and the number with limited English proficiency grew by 7.3 million (a 53 percent increase, see graph). Percentages of Americans Who Speak a Language Other Than English at Home or Who Have Limited English Proficiency.). The numbers are particularly high in some places: in 2000, 40 percent of Californians and 75 percent of Miami residents spoke a language other than English at home, and 20 percent of Californians and 47 percent of Miami residents had limited English proficiency.

Yet many patients who need medical interpreters have no access to them. According to one study, no interpreter was used in 46 percent of emergency department cases involving patients with limited English proficiency. Few clinicians receive training in working with interpreters; only 23 percent of U.S. teaching hospitals provide any such training, and most of these make it optional. Data collection on patients’ primary language and English proficiency is frequently inadequate or nonexistent. Although no federal statutes require the collection of such information, no statute prohibits it, either.

Language barriers can have deleterious effects. Patients who face such barriers are less likely than others to have a usual source of medical care; they receive preventive services at reduced rates; and they have an increased risk of nonadherence to medication. Among patients with psychiatric conditions, those who encounter language barriers are more likely than others to receive a diagnosis of severe psychopathology — but are also more likely to leave the hospital against medical advice. Among children with asthma, those who confront language barriers have an increased risk of intubation. Such patients are less likely than others to return for follow-up appointments after visits to the emergency room, and they have higher rates of hospitalization and drug complications. Greater resources are used in their care, but they have lower levels of patient satisfaction.

Inadequate communication can have tragic consequences: in one case, the misinterpretation of a single word led to a patient’s delayed care and preventable quadriplegia. A Spanish-speaking 18-year-old had stumbled into his girlfriend’s home, told her he was “intoxicado,” and collapsed. When the girlfriend and her mother repeated the term, the non–Spanish-speaking paramedics took it to mean “intoxicated”; the intended meaning was “nauseated.” After more than 36 hours in the hospital being worked up for a drug overdose, the comatose patient was reevaluated and given a diagnosis of intracerebellar hematoma with brain-stem compression and a subdural hematoma secondary to a ruptured artery. (The hospital ended up paying a $71 million malpractice settlement.)

In 1998, the Office for Civil Rights of the Department of Health and Human Services issued a memorandum regarding the prohibition, under Title VI of the Civil Rights Act of 1964, against discrimination on the basis of national origin — which affects persons with limited English proficiency. This memorandum states that the denial or delay of medical care because of language barriers constitutes discrimination and requires that recipients of Medicaid or Medicare funds provide adequate language assistance to patients with limited English proficiency. In 2000, a presidential executive order was issued on improving such persons’ access to services. Thirteen states currently provide third-party reimbursement (through Medicaid and the State Children’s Health Insurance Program) for interpreter services. Unfortunately, most of the states containing the largest numbers of patients with limited English proficiency have not followed suit, sometimes citing concerns about costs. Although the Office for Civil Rights issued guidelines in 2003 that seem to allow health care facilities to opt out of providing language services if their costs are too burdensome, Title VI provides no such exemption.

Ad hoc interpreters, including family members, friends, untrained members of the support staff, and strangers found in waiting rooms or on the street, are commonly used in clinical encounters. But such interpreters are considerably more likely than professional interpreters to commit errors that may have adverse clinical consequences. Ad hoc interpreters are also unlikely to have had training in medical terminology and confidentiality; their priorities sometimes conflict with those of patients; and their presence may inhibit discussions regarding sensitive issues such as domestic violence, substance abuse, psychiatric illness, and sexually transmitted diseases. It is especially risky to have children interpret, since they are unlikely to have a full command of two languages or of medical terminology; they frequently make errors of clinical consequence; and they are particularly likely to avoid sensitive issues. Given the documented risks associated with the use of ad hoc interpreters, it is of concern that the 2003 guidance from the Office for Civil Rights states that such use “may be appropriate.”

Later this year, the California legislature will consider a bill prohibiting state-funded organizations from using children younger than 15 years of age as medical interpreters. Leland Yee, the California speaker pro tempore, proposed the bill, prompted by his experiences interpreting for his mother and, later, as a child psychologist. The bill requires organizations receiving state funding to establish a procedure for “providing competent interpretation services that does not involve the use of children.”

Although this legislation may emerge as a state model, as an unfunded mandate, it will have limited power to improve care. Perhaps the time has come for payers to be required to reimburse providers for interpreter services. The provision of adequate language services results in optimal communication, patient satisfaction, outcomes, resource use, and patient safety. A 2002 report from the Office of Management and Budget estimated that it would cost, on average, only $4.04 (0.5 percent) more per physician visit to provide all U.S. patients who have limited English proficiency with appropriate language services for emergency-department, inpatient, outpatient, and dental visits. This seems like a small price to pay to ensure safe, high-quality health care for 49.6 million Americans.

SOURCE INFORMATION

Dr. Flores is director of the Center for the Advancement of Underserved Children and a professor of pediatrics, epidemiology, and health policy at the Medical College of Wisconsin and the Children’s Research Institute of the Children’s Hospital of Wisconsin, Milwaukee.

Glenn Flores, M.D.- New England Journal of Medicine 2006; 355:229-231 July 20, 2006 - original article: http://www.nejm.org/doi/full/10.1056/NEJMp058316